Day: June 13, 2012
-
FDA & EMA: Regulatory Bodies and Their Stand Vs. Bladder Cancer Risk
0 Likes Thank You! The European Medicines Agency (EMA) seemed to tilt toward the direction taken by the Food and Drugs Administration (FDA) regarding Actos (pioglitazone) bladder cancer risk. With the move of France to suspend sales